Home › Neuroblastoma › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Neuroblastoma sa Philadelphia, PA

9 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Philadelphia (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Nagre-recruitPhase 3

Children's Hospital of Philadelphia, Philadelphia
Saint Christopher's Hospital for Children, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo

Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Nagre-recruitPhase 3

Children's Hospital of Philadelphia, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo

365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia, Philadelphia

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Nagre-recruitPhase 1/2

Children's Hospital of Philedephia, Philadelphia

Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia, Philadelphia

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia

Edad 1 hanggang 31 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06450041

Neuroblastoma Biology Study

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Philadelphia, Philadelphia

31 Days – 99 Years · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Nagre-recruit

Children's Hospital of Philadelphia, Philadelphia

Hanggang edad 17 · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT06831552

Pag-aaral para sa Neuroblastoma sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.